Werewolf Therapeutics

IPO

Home Page | Werewolf Therapeutics Inc.

Watertown, United States · Founded 2017 · $206.0M raised

Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$206.0M
Last Round
$56.0M Series AAug 2026
Rounds
2

About

Werewolf Therapeutics is a clinical-stage biotechnology company founded in 2017 by Dan Hicklin, focused on developing a novel class of conditionally activated proinflammatory immune modulators—called WEREs (Agonists Regulated by the Environment)—that act selectively within the tumor microenvironment to treat cancer. The company's pipeline targets solid tumors and hematologic malignancies using its proprietary PREDATOR platform, which engineers cytokines and other immune-activating proteins to remain inert in healthy tissue while potently activating within tumors. Werewolf Therapeutics is publicly traded on Nasdaq under the ticker HOWL and is headquartered in the greater Boston, Massachusetts area.

Summary

Werewolf Therapeutics is a Biotech company based in Watertown, United States, founded in 2017. It has raised $206.0M in total across 2 rounds, most recently a $56.0M Series A round in Aug 2026. Investors include MPM Capital, Longwood Fund and Taiho Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Growth EquityGrowth EquityAug 2026
$150.0M

Sign up to see all 3 rounds

Series A through Growth Equity — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Werewolf Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/werewolf-therapeutics"><img src="https://indexed.vc/api/badge/company/werewolf-therapeutics" alt="Werewolf Therapeutics on Indexed.vc" width="260" height="76" /></a>